109 related articles for article (PubMed ID: 2352456)
1. Analysis of the deterioration rates of liver function in cirrhosis, based on galactose elimination capacity.
Marchesini G; Fabbri A; Bugianesi E; Bianchi GP; Marchi E; Zoli M; Pisi E
Liver; 1990 Apr; 10(2):65-71. PubMed ID: 2352456
[TBL] [Abstract][Full Text] [Related]
2. The quantitative liver function as measured by the galactose elimination capacity. II. Prognostic value and changes during disease in patients with cirrhosis.
Lindskov J
Acta Med Scand; 1982; 212(5):303-8. PubMed ID: 7180580
[TBL] [Abstract][Full Text] [Related]
3. The galactose elimination capacity and mortality in 781 Danish patients with newly-diagnosed liver cirrhosis: a cohort study.
Jepsen P; Vilstrup H; Ott P; Keiding S; Andersen PK; Tygstrup N
BMC Gastroenterol; 2009 Jun; 9():50. PubMed ID: 19566919
[TBL] [Abstract][Full Text] [Related]
4. Uncertainty in liver function assessment on the basis of single-point galactose concentration.
Fabbri A; Bianchi G; Brizi M; Zoli M; Marchesini G
Digestion; 1997; 58(4):379-83. PubMed ID: 9324166
[TBL] [Abstract][Full Text] [Related]
5. Quantitative liver function tests as surrogate markers for end-points in controlled clinical trials: a retrospective feasibility study.
Lotterer E; Högel J; Gaus W; Fleig WE; Bircher J
Hepatology; 1997 Dec; 26(6):1426-33. PubMed ID: 9397982
[TBL] [Abstract][Full Text] [Related]
6. The quantitative liver function as measured by the galactose elimination capacity. I. Diagnostic value and relations to clinical, biochemical, and histological findings in patients with steatosis and patients with cirrhosis.
Lindskov J
Acta Med Scand; 1982; 212(5):295-302. PubMed ID: 7180579
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of quantitative liver function tests in viral cirrhosis: a prospective study.
Addario L; Scaglione G; Tritto G; Di Costanzo GG; De Luca M; Lampasi F; Galeota Lanza A; Picciotto FP; Tartaglione MT; Utech W; Macr M; Giannelli E; Ascione A
Eur J Gastroenterol Hepatol; 2006 Jul; 18(7):713-20. PubMed ID: 16772827
[TBL] [Abstract][Full Text] [Related]
8. Assessment of liver function using a novel galactose single point method.
Tang HS; Hu OY
Digestion; 1992; 52(3-4):222-31. PubMed ID: 1334011
[TBL] [Abstract][Full Text] [Related]
9. Galactose elimination capacity as a prognostic marker in patients with severe acetaminophen-induced hepatotoxicity: 10 years' experience.
Schmidt LE; Ott P; Tygstrup N
Clin Gastroenterol Hepatol; 2004 May; 2(5):418-24. PubMed ID: 15118981
[TBL] [Abstract][Full Text] [Related]
10. The galactose elimination capacity test to monitor liver disease course in patients with Wilson's disease.
Munk DE; Björklund J; Lund Laursen T; Vilstrup H; Ott P; Grønbæk H; Damgaard Sandahl T
Scand J Gastroenterol; 2022 May; 57(5):589-594. PubMed ID: 34994677
[TBL] [Abstract][Full Text] [Related]
11. Age-dependency of galactose elimination capacity in healthy children and children with chronic liver disease.
Lange A; Grønbæk H; Vilstrup H; Keiding S
Scand J Gastroenterol; 2011 Feb; 46(2):197-200. PubMed ID: 21034348
[TBL] [Abstract][Full Text] [Related]
12. Use of quantitative liver function tests--caffeine clearance and galactose elimination capacity--after orthotopic liver transplantation.
Nagel RA; Dirix LY; Hayllar KM; Preisig R; Tredger JM; Williams R
J Hepatol; 1990 Mar; 10(2):149-57. PubMed ID: 2332584
[TBL] [Abstract][Full Text] [Related]
13. A simplified method to determine galactose elimination capacity in patients with liver disease.
Bergström M; Söderman C; Eriksson LS
Scand J Clin Lab Invest; 1993 Nov; 53(7):667-70. PubMed ID: 8272755
[TBL] [Abstract][Full Text] [Related]
14. Preoperative galactose elimination capacity predicts complications and survival after hepatic resection.
Redaelli CA; Dufour JF; Wagner M; Schilling M; Hüsler J; Krähenbühl L; Büchler MW; Reichen J
Ann Surg; 2002 Jan; 235(1):77-85. PubMed ID: 11753045
[TBL] [Abstract][Full Text] [Related]
15. Urinary sodium balance in patients with cirrhosis: relationship to quantitative parameters of liver function.
Wensing G; Lotterer E; Link I; Hahn EG; Fleig WE
Hepatology; 1997 Nov; 26(5):1149-55. PubMed ID: 9362355
[TBL] [Abstract][Full Text] [Related]
16. Novel galactose single point method as a measure of residual liver function: example of cefoperazone kinetics in patients with liver cirrhosis.
Hu OY; Tang HS; Chang CL
J Clin Pharmacol; 1995 Mar; 35(3):250-8. PubMed ID: 7608313
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of the galactose test in predicting survival of patients with cirrhosis evaluated for liver transplantation. A prospective multicenter Italian study. AISF Group for the Study of Liver Transplantation. Associazione Italiana per lo Studio del Fegato.
Salerno F; Borroni G; Moser P; Sangiovanni A; Almasio P; Budillon G; Capuano G; Muraca M; Marchesini G; Bernardi M; Marenco G; Molino G; Rossaro L; Solinas A; Ascione A
J Hepatol; 1996 Oct; 25(4):474-80. PubMed ID: 8912146
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of hepatic function in liver cirrhosis: clinical utility of galactose elimination capacity, hepatic clearance of D-sorbitol, and laboratory investigations.
Garello E; Battista S; Bar F; Niro GA; Cappello N; Rizzetto M; Molino G
Dig Dis Sci; 1999 Apr; 44(4):782-8. PubMed ID: 10219839
[TBL] [Abstract][Full Text] [Related]
19. Quantitative liver function in patients with rheumatoid arthritis treated with low-dose methotrexate: a longitudinal study.
Beyeler C; Reichen J; Thomann SR; Lauterburg BH; Gerber NJ
Br J Rheumatol; 1997 Mar; 36(3):338-44. PubMed ID: 9133966
[TBL] [Abstract][Full Text] [Related]
20. Estimation of the hepatic blood "flow" by galactose plasma clearance in patients with liver disease.
Zaramella MG; Vallini R; Tiribelli C
Liver; 1985 Jun; 5(3):129-33. PubMed ID: 4046751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
